Class of 2026
For cutting-edge research in activity-based protein profiling that established foundational chemical and proteomic technologies to map functional enzyme activity, uncovering oncogenic lipid-signaling pathways, revealing previously inaccessible therapeutic targets, and advancing both cancer diagnosis and the evolution of mechanism-based treatments.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]